Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Med Sci Monit ; 24: 5610-5618, 2018 Aug 12.
Artigo em Inglês | MEDLINE | ID: mdl-30099473

RESUMO

BACKGROUND Hypogonadotropic hypogonadism (HH), or secondary hypogonadism, results from reduced secretion of gonadotropins, including follicle-stimulating hormone (FSH) and luteinizing hormone (LH), by the pituitary gland, resulting in lack of production of sex steroids. The aim of this study was to evaluate self-reported sexual function in sexually active women with and without HH using two evaluation methods, the Female Sexual Function Index (FSFI) and the Beck Depression Inventory (BDI). MATERIAL AND METHODS The study recruited 88 women who attended an outpatient in vitro fertilization (IVF) clinic in Turkey for primary infertility, between August 2013 and August 2016. All patients were sexually active with an age that ranged from 20-41 years. Following an initial examination, including measurement of FSH and LH levels, all study participants were asked to complete the FSFI and BDI self-reporting questionnaires. Patients were divided into Group 1 (with HH) (N=42) and Group 2 (the control group) (N=46). RESULTS Analysis of the patient responses to questions regarding their sexual function in the FSFI and BDI showed that of the 42 patients in Group 1 (the HH group), 27 patients (64.28%) reported sexual dysfunction; of the 46 patients in Group 2 (the control group) 14 patients (30.34%) reported sexual dysfunction. Analysis of the FSFI lubrication scores and orgasm scores showed a statistically significant difference between the two groups (both, p<0.01). CONCLUSIONS Women with HH require both physical and psychological support to improve their sexual function, self-esteem, mental health, and quality of life.


Assuntos
Hipogonadismo/fisiopatologia , Hipogonadismo/psicologia , Disfunções Sexuais Fisiológicas/fisiopatologia , Disfunções Sexuais Fisiológicas/psicologia , Adulto , Depressão/diagnóstico , Depressão/fisiopatologia , Depressão/psicologia , Feminino , Hormônio Foliculoestimulante/metabolismo , Humanos , Hipogonadismo/diagnóstico , Infertilidade Feminina/diagnóstico , Infertilidade Feminina/fisiopatologia , Infertilidade Feminina/psicologia , Hormônio Luteinizante/metabolismo , Escalas de Graduação Psiquiátrica , Qualidade de Vida , Autorrelato , Disfunções Sexuais Fisiológicas/diagnóstico , Inquéritos e Questionários , Turquia
2.
J Matern Fetal Neonatal Med ; 27(10): 1020-2, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24060143

RESUMO

OBJECTIVE: In the present study, the effects of povidone iodine (PI) used during Caesarean operations on maternal thyroid hormones and urine iodine levels in the infant and the mother were investigated. DESIGN: Twenty-seven patients were allocated to the PI group I (Gr I), and 28 to the non-PI group (Group II). Maternal preoperative and 24th-h postoperative free T3 (fT3), freeT4 (fT4), TSH, and urine iodine levels were determined, as well as infant urine iodine values. RESULTS: In both groups, fT3 levels before and after the operation were found to be reduced (p < 0.01, p = 0.01, respectively). However, the decrease in fT3 was approximately 1.5-fold higher in Gr I than in Gr II. TSH levels increased significantly in Gr I (p = 0.005). The urine iodine levels of the mothers increased 25% in Gr I, but only 2% in Gr II. CONCLUSIONS: The absorption of PI by the skin was found to lead to changes in fT3, TSH, and urine iodine excretion values in the mothers. The findings of this study of Caesarean operations, which have a short duration, might be a signal to be careful of thyroid hormone effects in operations lasting longer.


Assuntos
Anti-Infecciosos Locais/efeitos adversos , Cesárea , Iodo/urina , Povidona-Iodo/efeitos adversos , Glândula Tireoide/efeitos dos fármacos , Hormônios Tireóideos/sangue , Administração Cutânea , Adulto , Anti-Infecciosos Locais/administração & dosagem , Biomarcadores/sangue , Biomarcadores/urina , Feminino , Humanos , Recém-Nascido , Avaliação de Resultados da Assistência ao Paciente , Povidona-Iodo/administração & dosagem , Gravidez , Testes de Função Tireóidea , Glândula Tireoide/metabolismo
3.
Am J Case Rep ; 14: 238-40, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23847711

RESUMO

PATIENT: Female, 46 FINAL DIAGNOSIS: Unilateral adneksial and renal agenesis Symptoms: Menometrorrhagia Medication: - Clinical Procedure: Total abdominal hysterectomy and unilateral salphingoopherectomy Specialty: Obstetrics and gynecology. OBJECTIVE: Rare disease. BACKGROUND: Unilateral renal and adnexal agenesis is quite rare. Absence of any uterine abnormality accompanying current urogenital abnormalities is even rarer. CASE REPORT: We report on the case of a 46-year-old multiparous woman, incidentally diagnosed to have unilateral renal, ovarian, and tubal agenesis just before hysterectomy due to menometrorrhagia and myoma uteri. CONCLUSIONS: Any diagnosis of a urogenital abnormality necessitates investigation of comorbid renal or genital abnormalities.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...